| Developers: | Canon Medical Systems Corp. (бывшая Toshiba Medical Systems) |
| Date of the premiere of the system: | March, 2018 |
2018: Announcement of Aplio i900
On March 10, 2018 the Canon Medical Systems company submitted the new cardiovascular ultrasonic Aplio i900 system. The improved visualization 2D and 4D will allow cardiologists to conduct complex cardiographic researches, using an economic, effective, least invasive and safest method of visualization of heart. At the same time new 4D-functions expand possibilities of cardiovascular ultrasonic visualization, and data retrieveds are used for optimization of already existing systems, says the producer.
The Aplio i900 system is a part of the ultrasonic platform of a premium class of Aplio i-series with the updated packet of 4D-functions. So, with its help carrying out 4D TEE транскатетерной procedures using new applications, including MVA (Mitral Valve Analysis) which allows to carry out quickly the analysis of the mitralny valve during planning of transaction, implantation and at postoperative assessment is possible. A system is supplied with the automated analytical and measuring tools allowing to estimate MPI (the index of activity of a myocardium) and the movement of a wall of a myocardium at 3D. These functions help to reveal early stages of coronary heart disease and to quantitatively estimate warm function.
Relying on the exclusive computing power of iPerformance, a system allows to set quickly and precisely the diagnosis. Aplio i900 is supplied with the iSense screen and a touch control.
 | Aplio i900 proposes to suppliers of medical services the complete solution covering a broad spectrum of cardiovascular researches including an ekhokardioskopiya, a stress-ekhokardioskopiyu and a chrespishchevodny ekhokardioskopiya at adults and children and also heart researches in the embryonic period, - the head of division of ultrasonic examination of Canon Medical Systems Dan Skiba explained.[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |